Home > Healthcare > Pharmaceuticals > Finished Drug Form > cephalosporin drugs market
Get a free sample of Cephalosporin Drugs Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Cephalosporin Drugs Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The cephalosporin drugs industry is characterized by diverse players competing in the industry. Pfizer Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, and Novartis AG, account for significant market share. These prominent players adopt a combination of strategic initiatives such as collaboration & partnership, global expansion strategies, research and development, product diversification, and regulatory compliance to maintain a competitive edge in the market.
Foremost players operating in the cephalosporin drugs industry are as mentioned below:
The global cephalosporin drugs industry was valued at USD 14.1 billion in 2023 and is estimated to grow at a CAGR of 3.1% between 2024 and 2032, attributed to growing number of generic medications, rising geriatric population, and advancements in drug discovery services.
The parenteral segment is expected to reach a notable market revenue of USD 11.3 billion by 2032, owing to the rapid and direct delivery of the drug into the bloodstream.
In 2023, North America held a significant share of 42.2% in the cephalosporin drugs market, backed by substantial investments in pharmaceuticals, including the purchase and use of cephalosporin drugs.
AbbVie Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.